BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9522439)

  • 1. Baculovirus-mediated expression of cytochrome P4502C8 and human NADPH-cytochrome P450 reductase: optimization of protein expression.
    Ong CE; Miners JO; Birkett DJ; Bhasker CR
    Xenobiotica; 1998 Feb; 28(2):137-52. PubMed ID: 9522439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP3A4 expressed by insect cells infected with a recombinant baculovirus containing both CYP3A4 and human NADPH-cytochrome P450 reductase is catalytically similar to human liver microsomal CYP3A4.
    Lee CA; Kadwell SH; Kost TA; Serabjit-Singh CJ
    Arch Biochem Biophys; 1995 May; 319(1):157-67. PubMed ID: 7771780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing bacterial expression of catalytically active human cytochromes P450: comparison of CYP2C8 and CYP2C9.
    Boye SL; Kerdpin O; Elliot DJ; Miners JO; Kelly L; McKinnon RA; Bhasker CR; Yoovathaworn K; Birkett DJ
    Xenobiotica; 2004 Jan; 34(1):49-60. PubMed ID: 14742136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and coupling of human cytochrome P450 2E1 and NADPH-cytochrome P450 oxidoreductase in dual expression and co-infection systems with baculovirus in insect cells.
    Wang MH; Patten CJ; Yang GY; Paranawithana SR; Tan Y; Yang CS
    Arch Biochem Biophys; 1996 Oct; 334(2):380-8. PubMed ID: 8900414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cDNA-directed expression of human cytochrome P450 CYP1A1 using baculovirus. Purification, dependency on NADPH-P450 oxidoreductase, and reconstitution of catalytic properties without purification.
    Buters JT; Shou M; Hardwick JP; Korzekwa KR; Gonzalez FJ
    Drug Metab Dispos; 1995 Jul; 23(7):696-701. PubMed ID: 7587956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform.
    Zeldin DC; DuBois RN; Falck JR; Capdevila JH
    Arch Biochem Biophys; 1995 Sep; 322(1):76-86. PubMed ID: 7574697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexpression of cytochrome P4502A6 and human NADPH-P450 oxidoreductase in the baculovirus system.
    Chen L; Buters JT; Hardwick JP; Tamura S; Penman BW; Gonzalez FJ; Crespi CL
    Drug Metab Dispos; 1997 Apr; 25(4):399-405. PubMed ID: 9107537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of Salmonella typhimurium YG7108 strains, each coexpressing a form of human cytochrome P450 with NADPH-cytochrome P450 reductase.
    Fujita K; Nakayama K; Yamazaki Y; Tsuruma K; Yamada M; Nohmi T; Kamataki T
    Environ Mol Mutagen; 2001; 38(4):329-38. PubMed ID: 11774365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competitive interactions between cytochromes P450 2A6 and 2E1 for NADPH-cytochrome P450 oxidoreductase in the microsomal membranes produced by a baculovirus expression system.
    Tan Y; Patten CJ; Smith T; Yang CS
    Arch Biochem Biophys; 1997 Jun; 342(1):82-91. PubMed ID: 9185616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional high level expression of cytochrome P450 CYP2D6 using baculoviral expression systems.
    Paine MJ; Gilham D; Roberts GC; Wolf CR
    Arch Biochem Biophys; 1996 Apr; 328(1):143-50. PubMed ID: 8638923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable expression of human cytochrome P450 3A4 in conjunction with human NADPH-cytochrome P450 oxidoreductase in V79 Chinese hamster cells.
    Schneider A; Schmalix WA; Siruguri V; de Groene EM; Horbach GJ; Kleingeist B; Lang D; Böcker R; Belloc C; Beaune P; Greim H; Doehmer J
    Arch Biochem Biophys; 1996 Aug; 332(2):295-304. PubMed ID: 8806738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.
    Rodrigues AD; Mulford DJ; Lee RD; Surber BW; Kukulka MJ; Ferrero JL; Thomas SB; Shet MS; Estabrook RW
    Drug Metab Dispos; 1995 Jul; 23(7):765-75. PubMed ID: 7587966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-incorporation of heterologously expressed Arabidopsis cytochrome P450 and P450 reductase into soluble nanoscale lipid bilayers.
    Duan H; Civjan NR; Sligar SG; Schuler MA
    Arch Biochem Biophys; 2004 Apr; 424(2):141-53. PubMed ID: 15047186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of human cytochrome P450 (CYP) in the metabolic activation of N-alkylnitrosamines: application of genetically engineered Salmonella typhimurium YG7108 expressing each form of CYP together with human NADPH-cytochrome P450 reductase.
    Fujita K; Kamataki T
    Mutat Res; 2001 Nov; 483(1-2):35-41. PubMed ID: 11600130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-expression of human cytochrome P4501A1 (CYP1A1) variants and human NADPH-cytochrome P450 reductase in the baculovirus/insect cell system.
    Schwarz D; Kisselev P; Honeck H; Cascorbi I; Schunck WH; Roots I
    Xenobiotica; 2001 Jun; 31(6):345-56. PubMed ID: 11513247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant baculovirus strategy for coexpression of functional human cytochrome P450 and P450 reductase.
    Lee CA; Kost TA; Serabjit-Singh CJ
    Methods Enzymol; 1996; 272():86-95. PubMed ID: 8791765
    [No Abstract]   [Full Text] [Related]  

  • 17. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
    Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
    Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid hydroxylation by human fetal CYP3A7 and human NADPH-cytochrome P450 reductase coexpressed in insect cells using baculovirus.
    Ohmori S; Fujiki N; Nakasa H; Nakamura H; Ishii I; Itahashi K; Kitada M
    Res Commun Mol Pathol Pharmacol; 1998 Apr; 100(1):15-28. PubMed ID: 9644715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of yeast-expressed human liver cytochrome P450 3A4 catalytic activities by coexpressing NADPH-cytochrome P450 reductase and cytochrome b5.
    Peyronneau MA; Renaud JP; Truan G; Urban P; Pompon D; Mansuy D
    Eur J Biochem; 1992 Jul; 207(1):109-16. PubMed ID: 1628642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The xenobiotic inhibitor profile of cytochrome P4502C8.
    Ong CE; Coulter S; Birkett DJ; Bhasker CR; Miners JO
    Br J Clin Pharmacol; 2000 Dec; 50(6):573-80. PubMed ID: 11136296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.